Abdelmoneim AS,Eurich DT,Gamble JM,Johnson JA,Seubert JM,Qiu W,Simpson SH .2014 .Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: A nested case-control study. Diabetes Obes. Metab., 16(1) : 22-29.
Alotaibi MR,Fatani AJ,Almnaizel AT,Ahmed MM,Abuohashish HM,Al-Rejaie SS .2019 .In vivo assessment of combined effects of glibenclamide and losartan in diabetic rats. Med, 28 : 178-185.
Alturkistani HA,Tashkandi FM,Mohammedsaleh ZM .2016 .Histological stains: A literature review and case study. Glob. J. Health Sci., 8(3) : 72-79.
Baiges A,Hernández-Gea V,Bosch J .2018 .Pharmacologic prevention of variceal bleeding and rebleeding. Hepatol. Int., 12(Suppl 1) : 68-80.
Brunner F,Berzigotti A,Bosch J .2017 .Prevention and treatment of variceal haemorrhage in 2017. , 37(Suppl 1) : 104-115.
Channa M and Janjua M .2003 .Effects of ciprofloxacin on foetal hepatocytes. JPMA, 53 : 448-450.
Chen J,Marciniak TA,Radford MJ,Wang Y,Krumholz HM Y .1999 .Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients1: Results from the national cooperative cardiovascular project. J. Am. Coll. Cardiol., 34 : 1388-1394.
Chounta A,Zouridakis S,Ellinas C,Tsiodras S,Zoumpouli C,Kopanakis S,Giamarellou H S .2005 .Cholestatic liver injury after glimepiride therapy. J. Hepatol., 42 : 944-946.
Dourakis SP,Tzemanakis E,Sinani C,Kafiri G,Hadziyannis SJ .2000 .Gliclazide-induced acute hepatitis. Eur. J. Gastroenterol. Hepatol., 12 : 119.
Dungan K,Merrill J,Long C,Binkley P C .2019 .Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients. Cardiovasc. Diabetol, 18 : 163.
El-Refaei MF,Abduljawad SH,Alghamdi AH .2014 .Alternative medicine in diabetes role of angiogenesis, oxidative stress and chronic inflammation. Rev. Diabet. Stud., 11(3-4) : 231-244.
Feroz Z,Khan RA .2013 .Hepatoprotective effect of herbal drug on CCl 4 induced liver damage. Pak. J. Pharm. Sci., 26(1) : 99-103.
Garcia-Compean D,Gonzalez-Gonzalez JA,LavalleGonzalez FJ,Gonzalez-Moreno EI,Maldonado-Garza HJ,Villarreal-Perez JZ .2015 .The treatment of diabetes mellitus of patients with chronic liver disease. Annal. Hepatol., 14(6) : 780-788.
Ie D ,Apis F .2015 .(Hymenoptera: Apidae). J. Appl. Nat. Sci., 7 : 324-327.
Diabetes Federation (IDF) Diabetes International,Atlas International .2019 .. (Access on 31 January, : .
Jayaraman R,Subramani S,Sheik Abdullah SH,Udaiyar M .2018 .Antihyperglycemic effect of hesperetin, a citrus flavonoid, extenuates hyperglycemia and exploring the potential role in antioxidant and antihyperlipidemic in streptozotocininduced diabetic rats. Biomed, 97 : 98-106.
Kamal P and Bhabhra R .2019 .Glipizide induced hepatotoxicity: A case report and review of literature. J. Diab. Metab. Disord., 6 : 028.
Kharroubi AT,Darwish HM .2015 .Diabetes mellitus: The epidemic of the century. World J. Diabetes., 6(6) : 850-867.
Kolaric TO,Nincevic V,Smolic R,Martina Smolic M and Wu GY R .2019 .Mechanisms of hepatic cholestatic drug injury. J. Clin. Transl, 7(1) : 86-92.
Li R,Bi Y,Vildhede A,Scialis RJ,Mathialagan S,Yang X,Marroquin LD,Lin J,Varma MVS .2017 .Transporter-mediated disposition, clinical pharmacokinetics and cholestatic potential of glyburide and its primary active metabolites. Drug Metab. Disposit, 45(7) : 737-747.
Luo X,Wang Z,Tsauo J,Zhou B,Zhang H,Li X .2015 .Advanced cirrhosis combined with portal vein thrombosis: A randomized trial of tips versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal variceal bleeding. , 276(1) : 286-293.
Lv W,Wang X,Xu Q,Lu W .2020 .Mechanisms and characteristics of sulfonylureas and glinides. Curr. Top. Med, 20(1) : 37-56.
Murtey MD,Ramasamy P,Janecek M,Kral R .2016 .Sample preparations for scanning electron microscopy life sciences, modern electron microscopy. In: Physical and Life Sciences, : .
Notenboom S,Weigand KM,Proost JH,van Lipzig MHM,van den Broek PHH,Greupink R,Russel FGM,Geny MM,Groothuis GMM .2018 .Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs. Eur. J. Pharm. Sci., 115 : 175-184.
Papazafiropoulou A,Melidonis A .2019 .Antidiabetic agents in patients with hepatic impairment. World J. Meta-Anal., 7(8) : 380-388.
Parasuraman S,Raveendran R,Kesavan R .2010 .Blood sample collection in small laboratory animals. J. Pharmacol. Pharmacother., 1(2) : 87-93.
Petrogiannopoulos C and Zacharof A .1997 .Glibenclamide and liver disease. Diab. Care, 20 : 1215.
Phemister J,Kapila A,Patel P,Mckinney JDO,Young M .2014 .Glyburide-induced cholestatic hepatitis. Ame. J. Gastroenterol., 109 : S367.
Rahmani AH,Hasanzadeh R,Nazari P .2016 .The complications and outcomes of oral antidiabetic drug poisoning in patients hospitalized at Razi hospital. World J. Pharm. Res., 5(11) : 153-160.
Sarges P,Steinberg JM,Lewis JH JM .2016 .Druginduced liver injury: Highlights from a review of the 2015 literature. , 39(9) : 801-821.
Scheen AJ .2014 .Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease. Expert Opin. Drug Metab. Toxicol., 10(6) : 839-857.
Sen S,Chakraborty R,De B R .2016 .Management of diabetes mellitus. In: Diabetes Mellitus in 21st Century. Springer Science+Business Media Singapore, : 13-22.
Sharma V,Janmeda P .2013 .Chemopreventive Role of Euphorbia neriifolia (Linn) and its isolated flavonoid against N-nitrosodiethylamine‒induced renal histopathological damage in male mice. Toxicol. Int., 20 : 101-107.
Sola D,Rossi L,Schianca GPC,Maffioli P,Bigliocca M,Mella R,Corliano F,Fra GP,Bartoli E,Derosa G .2015 .Sulfonylureas and their use in clinical practice. Arch. Med, 11(4) : 840-848.
Stokes A,Preston SH .2017 .Deaths attributable to diabetes in the United States: Comparison of data sources and estimation approaches. PLoS One, 12(1) : e0170219.
Subramanian G,Walmsley D,Blewitt R D .2003 .Gliclazide-induced hepatitis. Pract. Diab. Int., 20 : 18-20.
Swamy S,Krishna K,Nidavani RB K .2013 .Reversal of rosiglitazone hepatotoxicity by silymarin on rats. Int. J.Pharm. Sci. Res, 4 : 2301-2307.
Tholakanahalli VN,Potti A,Heyworth MF .1998 .Glibenclamide‒induced cholestasis. West. J. Med, 168 : 274-277.
Tolman KG,Freston JW,Kupfer S,Perez A .2009 .Liver safety in patients with type 2 diabetes treated with pioglitazone. Drug Saf, 32 : 787-800.
Tran L,Zielinski A,Roach AH,Jeneda JA,Householder AM,Cole EE,Atway EE,Amornyard M,Accursi ML,Shieh SW,Thompson EE .2015 .Pharmacologic treatment of type 2 diabetes: Oral medications. , 49(5) : 540-556.
van Basten J,van Hoek B,Zeijen R,Stockbrügger R .1992 .Glyburide-induced cholestatic hepatitis and liver failure. Case-report and review of the literature.Neth. J. Med, 40 : 305-307.
Villanueva C,Aracil C,Colomo A,Hernandez-Gea V,Lopez-Balaguer JM,Alvarez-Urturi C,Torras X,Balanzo J,Guarner C .2009 .Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterol., 137(1) : 119-128.
- .2020 .The top 10 causes of death. Accese on 30th June, : .
.2020 .. Accese on 30th June, : .
Zaman R,Kendall MJ,Biggs PI .1982 .The effect of acebutolol and propranolol on the hypoglycaemic. , : .
. .action of glibenclamide. Br. J. Clin. Pharmacol, 13(4) : .